Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Clancy

Showing results (11-20 of 121) with videos related to

Pageof 13
Sort By:
Annual Review of Genomics and Human Genetics|February 25, 2016
Cystic Fibrosis and Its Management Through Established and Emerging TherapiesDavid R Spielberg, John P Clancy
American Journal of Respiratory and Critical Care Medicine|December 19, 2017
MicroRNA-145, Cystic Fibrosis Transmembrane Conductance Regulator, and Transforming Growth Factor-β. An (Un)tangled Regulatory WebElizabeth L Kramer, John P Clancy
JAMA|January 31, 2019
Sweat Chloride TestingCormac McCarthy, John P Clancy, John Brewington
Proceedings of the American Thoracic Society|July 27, 2007
Detection of cystic fibrosis transmembrane conductance regulator activity in early-phase clinical trialsSteven M Rowe, Frank Accurso, John P Clancy
Clinics in Chest Medicine|November 7, 2022
Emerging Approaches to Monitor and Modify Care in the Era of Cystic Fibrosis Transmembrane Conductance RegulatorsClemente J Britto, Felix Ratjen, John P Clancy
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 4, 2003
The Caregiver Quality of Life Cystic Fibrosis (CQOLCF) scale: modification and validation of an instrument to measure quality of life in cystic fibrosis family caregiversWhitney Boling, David M Macrina, John P Clancy
Expert Opinion on Investigational Drugs|March 7, 2014
Nebulized liposomal amikacin for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis patientsZarmina Ehsan, Jacqueline Denise Wetzel, John P Clancy
Pediatric Pulmonology|March 19, 2019
Aerosolized agents for airway clearance in cystic fibrosisKevin W Southern, John P Clancy, Sarath Ranganathan
Journal of Computational and Graphical Statistics : a Joint Publication of American Statistical Association, Institute of Mathematical Statistics, Interface Foundation of North America|August 16, 2016
Bayesian Ensemble Trees (BET) for Clustering and Prediction in Heterogeneous DataLeo L Duan, John P Clancy, Rhonda D Szczesniak
Expert Review of Respiratory Medicine|November 20, 2015
Lumacaftor alone and combined with ivacaftor: preclinical and clinical trial experience of F508del CFTR correctionJohn J Brewington, Gary L McPhail, John P Clancy
Pageof 13

Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
Annual Review of Genomics and Human Genetics|February 25, 2016
Cystic Fibrosis and Its Management Through Established and Emerging TherapiesDavid R Spielberg, John P Clancy
American Journal of Respiratory and Critical Care Medicine|December 19, 2017
MicroRNA-145, Cystic Fibrosis Transmembrane Conductance Regulator, and Transforming Growth Factor-β. An (Un)tangled Regulatory WebElizabeth L Kramer, John P Clancy
JAMA|January 31, 2019
Sweat Chloride TestingCormac McCarthy, John P Clancy, John Brewington
Proceedings of the American Thoracic Society|July 27, 2007
Detection of cystic fibrosis transmembrane conductance regulator activity in early-phase clinical trialsSteven M Rowe, Frank Accurso, John P Clancy
Clinics in Chest Medicine|November 7, 2022
Emerging Approaches to Monitor and Modify Care in the Era of Cystic Fibrosis Transmembrane Conductance RegulatorsClemente J Britto, Felix Ratjen, John P Clancy
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 4, 2003
The Caregiver Quality of Life Cystic Fibrosis (CQOLCF) scale: modification and validation of an instrument to measure quality of life in cystic fibrosis family caregiversWhitney Boling, David M Macrina, John P Clancy
Expert Opinion on Investigational Drugs|March 7, 2014
Nebulized liposomal amikacin for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis patientsZarmina Ehsan, Jacqueline Denise Wetzel, John P Clancy
Pediatric Pulmonology|March 19, 2019
Aerosolized agents for airway clearance in cystic fibrosisKevin W Southern, John P Clancy, Sarath Ranganathan
Journal of Computational and Graphical Statistics : a Joint Publication of American Statistical Association, Institute of Mathematical Statistics, Interface Foundation of North America|August 16, 2016
Bayesian Ensemble Trees (BET) for Clustering and Prediction in Heterogeneous DataLeo L Duan, John P Clancy, Rhonda D Szczesniak
Expert Review of Respiratory Medicine|November 20, 2015
Lumacaftor alone and combined with ivacaftor: preclinical and clinical trial experience of F508del CFTR correctionJohn J Brewington, Gary L McPhail, John P Clancy
Pageof 13